Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues

Overview of attention for article published in BMC Cancer, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 4 news outlets
blogs: 1 blog

twitter: 3 X users
patent: 1 patent

Readers on

mendeley: 57 Mendeley

Summary News Blogs X Patents

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 19,724 followers.

Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against natural... https://t.co/SctIwebqwe

03 Feb 2018

Reply Repost Favourite

RT @dhovekamp42: $MDGEF Medigene #TCR bioinformatics: Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential #cross-…

04 Jan 2018

Reply Repost Favourite

$MDGEF Medigene #TCR bioinformatics: Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential #cross-reactivity against natural expressed proteins in human tissues https://t.co/B1hOtgOvFG

04 Jan 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.